BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Elixir Medical 

870 Hermosa Avenue

Sunnyvale  California  94085  U.S.A.
Phone: 408-636-2000 Fax: n/a


SEARCH JOBS




Industry
Medical Device






 Company News
Successful Live Case Demonstration Of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System At EuroPCR 5/21/2014 6:45:12 AM
Elixir Medical's Breakthrough Coronary Scaffold System Receives CE Mark Approval 5/13/2014 6:50:30 AM
Elixir Medical To Present At J.P. Morgan Healthcare Conference 1/6/2014 6:52:02 AM
Elixir Medical Announces Excellent 1-Year Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve® Novolimus Eluting Coronary Scaffold System 10/31/2013 7:47:22 AM
Elixir Medical Announces Outstanding Two-Year Results From the EXCELLA BD Randomized Clinical Trial for the CE Mark-Approved DESyne® BD System With Biodegradable Polymer Coating 5/24/2013 10:14:22 AM
Elixir Medical Announces Excellent Six-Month Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve® Novolimus Eluting Coronary Scaffold System at Late Breaking Clinical Trial Session of EuroPCR 5/21/2013 10:47:07 AM
Elixir Medical's DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System CE Marked 5/15/2013 7:21:22 AM
Elixir Medical Goes Head-to-Head Against Medtronic, Inc. (MDT) With Its DESyne Nx DES Study 5/14/2013 9:01:08 AM
Elixir Medical Announces FDA Approval to Commence EXCELLA III Clinical Trial with DESyne® Nx Novolimus Eluting Coronary Stent System in the United States 5/8/2013 11:06:04 AM
Elixir Medical to Present at J.P. Morgan Healthcare Conference 12/21/2012 6:25:42 AM
1234